Abstract
Red cell distribution width (RDW) measures red cells’ size variability. Metastatic ovarian cancer displays poor chemotherapy response without an effective prognostic predictor address. we investigated whether RDW correlates independently with survival outcomes in metastatic ovarian cancer treated by chemotherapy. Subsequently, it has been specified that RDW can be likewise utilized as a prognostic marker of metastatic ovarian cancer patients. Venous blood was collected from each patient in the morning. RDW was obtained directly by the hematology analyzer from 55 patients with metastatic ovarian cancer and were retrospectively analyzed between 2018 and 2022. Survival time was calculated from the date of chemotherapy initiation until the date of death.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
